Case Reports in Urology
Volume 2015 (2015), Article ID 747261, 7 pages
http://dx.doi.org/10.1155/2015/747261

Case Report

Metastatic Tumor of the Spermatic Cord in Adults: A Case Report and Review

Daisaku Hirano,¹ Mizuho Ohkawa,¹ Ryo Hasegawa,¹ Norimichi Okada,² Naoki Ishizuka,² and Yoshiaki Kusumi³

¹Department of Urology, Higashimatsuyama Municipal Hospital, Higashimatsuyama 355-0005, Japan
²Department of Surgery, Higashimatsuyama Municipal Hospital, Higashimatsuyama 355-0005, Japan
³Department of Pathology, Nihon University School of Medicine, Tokyo, Japan

Received 27 September 2015; Accepted 18 November 2015

Academic Editor: Sandhya Srinivas

Copyright © 2015 Daisaku Hirano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Metastatic spermatic cord (SC) tumor is extremely rare. Recently, we experienced a case of late-onset metastatic SC tumor from cecal cancer. This case is a 68-year-old man presenting with a painless right SC mass. He had undergone a right hemicolectomy for cecal cancer 6 years ago. Radical orchiectomy and adjuvant chemotherapy with S-1 were performed. No recurrence was found after one year of follow-up. We identified a total of 25 cases, including our case, on a literature search via PubMed from January 2000 to April 2015. The most frequent primary sites of the tumors metastasizing to the SC were the stomach (8 cases, 32%) and the colon (8 cases, 32%), next the liver (2 cases, 8%), and kidney (2 cases, 8%). The majority of the cases underwent radical orchiectomy for the metastatic tumors of the SC. Over half of the cases received adjuvant interventions based on the regimens for the primary tumors. Prognosis in the patients with metastatic tumor of the SC was unfavorable except for late-onset metastasis. In patients with a mass in the SC and a history of neoplasm, especially in gastrointestinal tract, the possibility of metastasis from the primary cancer should be considered.

1. Introduction

Tumors arising from the spermatic cord (SC) are rare and most of these tumors are benign such as lipoma. However, approximately 25% are potentially life-threating malignant neoplasms [1]. The most common malignant tumors comprise sarcomas such as liposarcoma, leiomyosarcoma, rhabdomyosarcoma, and malignant fibrous histiocytoma and occur as a result of a mutation of a pluripotent mesenchymal cell that transforms into a malignant population clones [2].

On the other hand, metastatic SC tumor is even more unusual [3]. Several investigators have indicated that the most frequent primary tumors metastasizing to the SC and peritesticular tissues have been neoplasms of the stomach and prostate [4]. The timings of the detection of SC metastasis in most previous reports have been synchronous or metachronous, and the majority of cases in the metachronous were found in less than several years after the treatment for primary tumors [4]. Recently, we experienced a patient with cecal cancer recurrence in the SC that occurred on late phase after radical hemicolectomy. Herein, we report this case and a review of the recent literatures.

2. Case Report

A 68-year-old man was referred to the Department of Urology from the Surgery at Higashimatsuyama Municipal Hospital with a right painless inguinal mass in April 2014. He had noticed it 6 months previously and observed an increase of its size. He had undergone right radical hemicolectomy for cecal cancer 6 years ago. Histological examination of the extirpated colon specimen showed moderately differentiated adenocarcinoma (Figure 1(a)) with depth of invasion of subserosa, lymphovascular invasion, and metastasis of the paracolic lymph nodes.

(a)

(b)

(c)

(d)

Figure 1: Histopathology. (a) Primary cecal cancer reveals moderately differentiated adenocarcinoma. (b) Spermatic cord tumor shows moderately differentiated adenocarcinoma, which is compatible with a metastasis from the cecal cancer. (c) Immunohistochemical staining indicates caudal-type homeobox- (CDX-) 2 positive in the spermatic cord tumor. (d) Immunohistochemical staining shows cytokeratin- (CK-) 20 positive in the spermatic cord tumor.

On physical examination, an approximately 4 × 3 cm palpable relatively fixed unpainful mass was observed in the right inguinal region. Abdominal computed tomography (CT) scan showed a heterogeneously slight-enhanced mass with noncapsulated irregular shape, 3.7 cm in diameter, suspicious of extending to the adjunct structures (Figure 2). Serum carcinoembryonic antigen (CEA) value was slightly elevated to 7.0 ng/mL (normal range < 5.0 ng/mL) but the levels of other tumor markers such as carbohydrate antigen 19-9 (CA19-9) and prostate-specific antigen (PSA) were normal. We did not deny that this tumor had been potentially malignant based on the clinical findings.

Figure 2: Abdominal CT. Abdominal CT reveals a 3.7 cm diameter slightly enhanced tumor (arrrow) in the right spermatic cord.

The patient underwent right radical orchiectomy. During the operation, the tumor was located in the SC and showed relatively invasive growth to the adjunct structures but did not invade the epididymis and testis. The resected specimen involved a 4.5 × 3.5 × 3 cm solid mass, with grayish-white tumor in the cut surface, and was located in the lower part of the SC (Figure 3).

Figure 3: Gross appearance of the resected tumor. Gross examination shows grayish-white mass (arrrow) in the cut surface of the resected tumor.

A histological examination of the SC tumor showed moderately differentiated adenocarcinoma (Figure 1(b)). In an immunohistochemical examination, the tumor cells in the SC were stained for caudal-type homeobox- (CDX-) 2 (Figure 1(c)) and cytokeratin- (CK-) 20 (Figure 1(d)). Based on the histopathological and immunohistochemical findings, the SC tumor was compatible with a metastasis from the cecal cancer.

The postoperative course was uneventful. The patient received adjuvant chemotherapy with tegafur/gimeracil/oteracil (S-1) which is a combined oral chemotherapeutic agent and has been doing well without evidence of recurrence for one year following the surgery.

3. Discussion

The SC is an extremely rare site for distant metastasis from a malignant neoplasm. In an autopsy study there were only two metastatic sites (0.01%) of the SC among 13,500 autopsy cases, both of which were from a primary gastric cancer [3]. The most common primary origin of a SC metastasis was the stomach, followed by the prostate, ileum, kidney, and colon as previously reviewed by Algaba et al. [4]. That review is over thirty years old and to our knowledge, there have not been any reviews involving recent cases. We performed a literature search of the case reports on adult metastatic SC tumor via PubMed from January 2000 to April 2015. Table 1 shows identified cases [5–27] including our case since 2000. The mean age of incidence was 61 years (range: 36 to 85 years). The overall incidence was similar on both sites, but with respect to the colon cancers as the primary site the ascending colon and cecal cancers metastasized to the right SC while the descending colon and sigmoid cancers metastasized to the left SC. The most presenting symptoms were a mass in inguinal sites and scrotal swelling, both with and without pain except for one case that was incidentally found in an orchiectomy specimen due to the treatment of prostate cancer. The average metastatic tumor size of the SC in the identified 15 cases was 3.6 cm in a diameter (range: 1.6 to 6.5 cm). The most frequent primary origin of the tumor was the stomach (8 cases, 32%) and colon (8 cases, 32%), followed by liver (2 cases, 8%) and kidney (2 cases, 8%), and one case occurring in the small bowel, gastrointestinal tract, pancreas, lung, and prostate each. The average time between diagnosis of primary tumor and the presence of metastasis to the SC in the 15 metachronous cases (60%) was 42 months (range: 2 to 108 months), while seven cases (28%) were synchronously detected and three cases (12%) were found as an occult cancer. The metastatic SC tumors extending to the epididymitis were found in six (32%) of the identified 19 cases, of which two cases (11%) invaded the testis.

Table 1: Reports of metastatic tumors of the spermatic cord in adults since 2000.

Case number
Author (year)
Age
Site
Symptoms
Tumor size (SC) in diameter, cm
Primary site
Duration of detection of SC metastasis from primary site diagnosis
Histopathology (SC tumor)
Involved structure
Treatment (SC tumor)
Prognosis after treatment

1
Ota et al. [5] (2000)
51
Left
Painless scrotal swelling
2.5
Stomach
9 years
Poorly differentiated adenocarcinoma
Epididymis and parietal tunica vaginalis
Radical orchiectomy + chemo (MTX, 5-FU)
Died, 1 year

2
Polychronidis et al. [6] (2002)
63
Left
Painless scrotal swelling
2
Colon (sigmoid)
Occult
Mucus-secreting adenocarcinoma
Intact
Radical orchiectomy
ND

3
Bawa et al. [7] (2003)
85
Left
Incidentally found by castration
ND
Prostate
Synchronous
Adenocarcinoma
Vas deferens
Radical orchiectomy + hormone therapy
ND

4
Salesi et al. [8] (2004)
62
Left
Mass in scrotum
ND
Gastrointestinal tract
Occult
Adenocarcinoma
Epididymitis
Orchifunicolectomy + chemo (CDDP, Epirubicin, 5-FU)
Died, 5 months

5
Bandyopadhyay et al. [9] (2005)
67
Right
Mass in groin
ND
Pancreas
Synchronous
Moderately differentiated adenocarcinoma
ND
Radical orchiectomy + distal pancreatectomy
ND

6
Kaya et al. [10] (2006)
62
Left
Painful mass in inguinal site
4.5
Lung
Synchronous
Non-small cell adenocarcinoma
Intact
Radical orchiectomy
Died, 2 weeks

7
Shida et al. [11] (2006)
75
Left
Mass in inguinal site
5
Colon (ascending)
2 months
Poorly differentiated adenocarcinoma
Intact
Radical orchiectomy
Died, 6 months

8
Miyake et al. [12] (2007)
60
Right
Mass in inguinal site
3
Colon (ascending)
1 year and 8 months
Moderately differentiated adenocarcinoma
Intact
Radical orchiectomy
ND

9
Paravastu et al. [13] (2007)
62
Left
Painless scrotal swelling
ND
Colon (descending)
Synchronous
Poorly differentiated adenocarcinoma
Intact
Radical orchiectomy + chemo (irinotecan, fluorouracil, cetuximab)
Alive, 18 months

10
Galanis et al. [14] (2009)
80
Right
Painful mass in inguinal site
ND
Colon (cecum, ascending, sigmoid)
Synchronous
Adenocarcinoma
Intact
Radical orchiectomy
Died, early postoperative period

11
Chang et al. [15] (2009)
38
Right
Scrotal enlargement and chronic testicular pain
ND
Liver
7 months
Cholangiocarcinoma (Klatskin tumor)
ND
Biopsy of the spermatic cord tumor careful surveillance
Alive, 5 months

12
Correa et al. [16] (2009)
57
Left
Mass in inguinal site
5
Left kidney
Synchronous
Renal cell carcinoma clear cell type
ND
Radical orchiectomy + radical nephrectomy + Sunitinib
Alive, 1 year

13
Schaefer et al. [17] (2010)
64
Right
Painful mass in groin and scrotum
2
Stomach
Synchronous
Signet ring cell carcinoma
Epididymitis and testis
Radical orchiectomy + chemo (paclitaxel, leucovorin, 5-FU: FLF regimen)
Died, 1 year

14
Ishibashi et al. [18] (2011)
71
Right
Mass in groin
3.8
Colon (cecum)
1 year
Well-differentiated adenocarcinoma
Intact
Radical orchiectomy + chemo (S-1)
Alive, 15 months without recurrence

15
Chiang et al. [19] (2011)
57
Right
Painful hard mass in inguinal site
2
Liver
6 years
Hepatocellular carcinoma
Intact
Radical orchiectomy + adjuvant radiotherapy
Alive, 6 months without recurrence

16
Mohammadi et al. [20] (2011)
57
Left
Painless mass in high scrotal site
6.5
Left kidney
3 years
Renal cell carcinoma (clear cell type)
ND
Tumor resection with preserved testis
Alive, 3 months without recurrence

17
Al-Ali et al. [21] (2012)
77
Left
Inguinal and testicular pain
ND
Colon (descending)
2.5 years
Adenocarcinoma
Epididymitis and capsule of the testis
Radical orchiectomy
ND

18
Lee et al. [22] (2012)
57
Left
Mass in inguinal site
4
Stomach
3 years
Poorly differentiated adenocarcinoma
Intact
Radical orchiectomy
ND

19
Watanabe et al. [23] (2013)
52
Right
Mass in inguinal and scrotal site
2
Stomach
2 years
Poorly differentiated adenocarcinoma
ND
Radical orchiectomy + chemo (CDDP)
Died, 10 months

20
Valizadeh et al. [24] (2013)
36
Right
Painful mass in inguinal site
1.6
Small bowel
Occult
Adenocarcinoma
ND
Radical orchiectomy + small bowel tumor resection + chemo (capecitabine plus oxaliplatin regimen)
Alive, 6 months without recurrence

21
Kanazawa et al. [25] (2013)
66
Right
Groin pain
4.2
Stomach
1 year
Moderately differentiated tubular adenocarcinoma
ND
Tumor resection with preserved testis + chemo
ND

22
Xu and Wang [26] (2013)
50
Bil
Mass in spermatic cords
ND
Stomach
4 years
Signet ring cell carcinoma
Epididymitis and seminiferous duct
Radical orchiectomy
ND

23
Kim et al. [27] (2014), Case 1
49
Right
Mass in scrotum with discomfort in spermatic cord
4
Stomach
7 years
Mucinous adenocarcinoma with signet ring cell carcinoma
Epididymitis
Radical orchiectomy + chemo (folinic acid, fluorouracil, oxaliplatin; FOLFOX regimen)
Alive, 26 months without recurrence

24
Case 2
60
Left
Inguinal pain
3.5
Stomach
6 years
Mucinous moderately differentiated adenocarcinoma
Intact
Radical orchiectomy + adjuvant radiation
Alive, 20 months without recurrence

25
Present study
68
Right
Painless mass in inguinal site
4.5
Colon (cecum)
6 years
Moderately differentiated adenocarcinoma
Intact
Radical orchiectomy + chemo (S-1)
Alive, 12 months without recurrence

S-1: tegafur/gimeracil/oteracil.

ND: Not document, SC: Spermatic cord.

The vast majority of cases as well as our case underwent radical orchiectomy for the metastatic tumors in the SC, while tumor resection alone with preservation of the testis was found in two cases (8%). Over half of the cases received adjuvant interventions such as chemotherapy, molecular therapy, or hormone therapy based on the regimens for the primary tumors.

The prognosis of a metastatic tumor in the SC has been typically unfavorable as previously reported [4]. In this review, the 2-year survival rate in the postmetastasis to the SC was 36% in a total of the 16 patients identified since 2000, including our case, using the Kaplan-Meier method with a median follow-up duration of 12 months (range: 0.47 to 26 months) (Figure 4). Although there have been a small number of cases and short follow-up duration, the prognosis in patients with a metastatic SC tumor seems to be unfavorable even in the recent cases. However, the patients with late-onset (6 years or more) metastasis to the SC are likely to be a favorable prognosis because four (80%) of the five patients had been alive without recurrence after radical orchiectomy with a mean follow-up duration of 16 months.

Figure 4: Survival after metastasis to the spermatic cord in the identified cases since 2000.

The mechanisms of metastasis to the SC and paratesticular tissues from primary malignant neoplasms have not been precisely elucidated. However, several possibilities have been proposed. The main routes have been postulated to be vascular and lymphatic routes. Other routes involving retrograde extension through the vessel, either along its lumen or by direct extension via the wall of the vessel, and transperitoneal seeding through the patent tunica vaginalis have been proposed [3, 4]. In our case hematogenous or lymphatic spread may be possible due to the positive lymphovascular invasion as well as the evidence of the paracolic lymph nodes metastasis in the primary neoplasm, and the late recurrence after the treatment of the primary site may be related to the activation of long-lasting tumor dormancy in distant organs including the SC.

In conclusion SC solid masses are usually not considered as SC metastasis from primary neoplasms such as gastrointestinal tract cancers previously treated with a curative intention. We did not initially consider this case to be a metastasis from cecal cancer. However, in patients with solid mass of the SC and a history of neoplasm, especially in the gastrointestinal tract, and even though the primary neoplasm has been treated with a curative intent long time earlier, the solid mass of the SC should be kept in mind in a possibility of metastasis from the primary tumor.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images and extirpated specimens.

Conflict of Interests

The authors declare that there is no conflict of interests as to the publication of this paper.

Authors’ Contribution

Daisaku Hirano contributed to writing the paper including acquisition and analysis of data and surgery. Mizuho Ohkawa contributed to acquisition of data especially regarding prior reported cases. Ryo Hasegawa, Norimichi Okada, and Naoki Ishizuka contributed to surgery. Yoshiaki Kusumi contributed to carrying out the pathologic confirmation. All authors read and approved the final paper.

References

D. Rodríguez and A. F. Olumi, “Management of spermatic cord tumors: a rare urologic malignancy,” Therapeutic Advances in Urology, vol. 4, no. 6, pp. 325–334, 2012.

M. Arlen, H. Grabstald, and W. F. Whitmore Jr., “Malignant tumors of the spermatic cord,” Cancer, vol. 23, no. 3, pp. 525–532, 1969.

N. Dutt, A. W. Bates, and S. I. Baithun, “Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children,” Histopathology, vol. 37, no. 4, pp. 323–331, 2000.

F. Algaba, J. M. Santaularia, and H. Villavicencio, “Metastatic tumor of the epididymis and spermatic cord,” European Urology, vol. 9, no. 1, pp. 56–59, 1983.

T. Ota, M. Shinohara, M. Tanaka et al., “Spermatic cord metastases from gastric cancer with elevation of serum hCG-β: a case report,” Japanese Journal of Clinical Oncology, vol. 30, no. 5, pp. 239–240, 2000.

A. Polychronidis, C. Tsolos, E. Sivridis, S. Botaitis, and C. Simopoulos, “Spermatic cord metastasis as an initial manifestation of sigmoid colon carcinoma: report of a case,” Surgery Today, vol. 32, no. 4, pp. 376–377, 2002.

A. S. Bawa, R. Singh, V. K. Bansal, and R. S. Punia, “Spermatic cord metastasis from prostatic cancer,” Journal of Postgraduate Medicine, vol. 49, no. 1, pp. 97–98, 2003.

N. Salesi, A. Fabi, B. Di Cocco et al., “Testis metastasis as an initial manifestation of an occult gastrointestinal cancer,” Anticancer Research, vol. 24, no. 2, pp. 1093–1096, 2004.

D. Bandyopadhyay, C. R. Kapadia, and P. E. Da Costa, “Pancreatic carcinoma: report of two cases presenting with unusual metastases,” Indian Journal of Gastroenterology, vol. 24, no. 2, pp. 75–76, 2005.

C. Kaya, H. Tanrikulu, G. Yilmaz, F. Aker, and M. I. Karaman, “Spermatic cord metastasis as an initial manifestation of non-small cell carcinoma of the lung,” International Journal of Urology, vol. 13, no. 6, pp. 846–848, 2006.

Y. Shida, Y. Miyata, T. Igawa, H. Sakai, S. Koga, and H. Kanetake, “A case of metastatic tumor of spermatic cord from ascending colon carcinoma,” Hinyokika kiyo. Acta urologica Japonica, vol. 52, no. 9, pp. 733–735, 2006.

Y. Miyake, T. Kato, K. Katayama et al., “A case of ascending colon carcinoma metastasized to an inguinal hernia sac,” Gan To Kagaku Ryoho, vol. 34, no. 12, pp. 2016–2018, 2007.

S. C. V. Paravastu, M. Batra, and K. Ananthakrishnan, “Colonic carcinoma masquerading as scrotal swelling: a case report and review of literature,” TheScientificWorldJOURNAL, vol. 7, pp. 855–859, 2007.

I. Galanis, G. Chatzimavroudis, A. Katsougiannopoulos, N. Galanis, J. Makris, and K. Atmatzidis, “Spermatic cord metastasis presenting as strangulated inguinal hernia—first manifestation of a multifocal colon adenocarcinoma: a case report,” Cases Journal, vol. 2, no. 1, article 61, 2009.

Y.-H. Chang, C.-K. Chuang, K.-F. Ng, and S.-K. Liao, “Klatskin tumor with spermatic cord metastasis: a case report,” Chang Gung Medical Journal, vol. 32, no. 1, pp. 104–107, 2009.

J. J. Correa, M. Fishman, S.-T. Chuang, and P. E. Spiess, “Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasis,” Clinical Genitourinary Cancer, vol. 7, no. 3, pp. E101–E103, 2009.

I.-M. Schaefer, U. Sauer, M. Liwocha, H. Schorn, H. Loertzer, and L. Füzesi, “Occult gastric signet ring cell carcinoma presenting as spermatic cord and testicular metastases: ‘Krukenberg tumor’ in a male patient,” Pathology Research and Practice, vol. 206, no. 7, pp. 519–521, 2010.

K. Ishibashi, N. Chika, T. Miyazaki et al., “Spermatic cord metastasis from colon cancer: report of a case,” Surgery Today, vol. 41, no. 3, pp. 418–421, 2011.

H. C. Chiang, P. H. Chen, and H. J. Shih, “Spermatic cord metastasis of primary hepatocellular carcinoma presenting as an inguinal mass: a case report,” ISRN Oncology, vol. 2011, Article ID 612753, 3 pages, 2011.

A. Mohammadi, K. Malhdoomi, and M. Ghasemi-rad, “Metachronous metastasis to the spermatic cord from renal cell carcinoma presenting as a high scrotal mass: a case report,” Cancer Imaging, vol. 11, no. 1, pp. 163–165, 2011.

B. M. Al-Ali, H. Augustin, H. Popper, and K. Pummer, “A case of descending colon carcinoma metastasized to left spermatic cord, testis, and epididymis,” Central European Journal of Urology, vol. 65, no. 2, pp. 94–95, 2012.

K. Y. Lee, S. J. Park, S. K. Moon, and H. C. Kim, “Unilateral spermatic cord metastasis from gastric cancer: a case report,” Iranian Journal of Radiology, vol. 9, no. 4, pp. 217–219, 2012.

R. Watanabe, K. Inada, Y. Yamashita, and A. Oka, “A case of metastatic tumor of the spermatic cord from gastric cancer,” Hinyokika Kiyo, vol. 59, no. 3, pp. 195–199, 2013.

N. Valizadeh, A. E. Oskuie, and A. Tehranchi, “Spermatic cord metastasis as early manifestation of small bowel adenocarcinoma,” Urology Annals, vol. 5, no. 1, pp. 53–55, 2013.

Y. Kanazawa, S. Kato, I. Fujita et al., “Spermatic cord tumor metastatic from stomach cancer 1 year after curative gastrectomy,” Journal of Nippon Medical School, vol. 80, no. 4, pp. 318–323, 2013.

F. Xu and Y. Wang, “Metastatic tumour of spermatic cords, epididymis and seminiferous duct from gastric carcinoma,” West Indian Medical Journal, vol. 62, no. 9, pp. 859–860, 2013.

J. H. Kim, D. S. Kim, H. D. Cho, and M. S. Lee, “Late-onset metastatic adenocarcinoma of the spermatic cord from primary gastric cancer,” World Journal of Surgical Oncology, vol. 12, no. 1, article 128, 2014.